ROTOP Pharmaka is a leading pharmaceutical company in the field of nuclear medicine and molecular imaging. In our production building at Helmholtz-Center Dresden-Rossendorf, radiopharmaceuticals are manufactured in two clean room facilities for nuclear medicine diagnostics of functional disorders and for oncology investigations.
Jens Junker has been Managing Director and CEO of ROTOP Pharmaka and ROTOP Radiopharmacy since September 2014. He is supported by Dr. Wilhelm Zörgiebel, main shareholder of ROTOP.
The extended management includes Dr. Antje Sterger (ppa.) as Chief Operating Officer.